Armata Pharmaceuticals, Inc.
Clinical trials sponsored by Armata Pharmaceuticals, Inc., explained in plain language.
-
New weapon against staph blood infections shows promise in early trial
Disease control CompletedThis study tested a new medicine called AP-SA02, given through a vein, for adults with a serious Staph bloodstream infection. The goal was to see if adding this treatment to standard antibiotics is safe and helps people get better faster. 56 adults took part, and researchers trac…
Phase: PHASE1, PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
Virus-Eating therapy inhaled to fight stubborn lung bug
Disease control CompletedThis study tested an inhaled treatment made from viruses that attack bacteria (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. The goal was to see if the therapy could safely reduce the amount of bacteria in the lungs. Participants received eithe…
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 09:50 UTC